Oppenheimer on Climb Bio (CLYM): 'Positive CLYM116 Reveal Carves Path Forward in IgAN'
Tweet Send to a Friend
Oppenheimer analyst Leland Gershell reiterated an Outperform rating and $10.00 price target on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
